| Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers | |
| Jianjiang Xie1; Weishen Yao2; Lingxiu Chen3; Wenjun Zhu4; Qiang Liu5; Geng Geng6; Jing Fang7; Yang Zhao8; Li Xiao7; Zhenhua Huang9; Jing Zhao4 | |
| 2023 | |
| Source Publication | BMC CANCER
 |
| ISSN | 1471-2407 |
| Volume | 23Issue:1Pages:1-10 |
| Abstract | Circulating tumor DNA (ctDNA) has been becoming a novel convenient and noninvasive method for dynamically monitoring landscape of genomic information to guild personalized cancer treatment. In this study we comprehensively evaluated the additional value of plasma ctDNA to routine tissue next generation sequencing (NGS) of therapeutically targetable mutations in lung cancers. |
| Language | 英语 |
| Document Type | 期刊论文 |
| Identifier | http://ir.imr.ac.cn/handle/321006/177175 |
| Collection | 中国科学院金属研究所 |
| Affiliation | 1.中国科学院广州地球化学研究所 2.Nanhai District People’s Hospital of Foshan 3.重庆大学 4.华中科技大学 5.中国科学院金属研究所 6.华东师范大学 7.厦门大学 8.上海交通大学 9.南方医科大学 |
| Recommended Citation GB/T 7714 | Jianjiang Xie,Weishen Yao,Lingxiu Chen,et al. Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers[J]. BMC CANCER,2023,23(1):1-10. |
| APA | Jianjiang Xie.,Weishen Yao.,Lingxiu Chen.,Wenjun Zhu.,Qiang Liu.,...&Jing Zhao.(2023).Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers.BMC CANCER,23(1),1-10. |
| MLA | Jianjiang Xie,et al."Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers".BMC CANCER 23.1(2023):1-10. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment